In Vitro Susceptibility of Bacterial Keratitis Isolates to Fourth-Generation Fluoroquinolones
Open Access
- 1 March 2010
- journal article
- research article
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 20 (2) , 300-305
Abstract
Purpose.: To study the microbiological profile of bacterial keratitis in Northern India and to determine the antibiotic sensitivity pattern of bacterial keratitis isolates to fourth-generation fluoroquinolones. Methods.: Laboratory records of all consecutive cases of clinically suspected bacterial corneal ulcers were retrospectively reviewed. Data noted included microorganism isolated and antibiotic culture sensitivity to cefazolin, tobramycin, gatifloxacin, and moxifloxacin. In vitro susceptibility toward individual antibiotics was determined and compared with the potential in vitro susceptibilities to cefazolin-tobramycin, cefazolin-gatifloxacin, and cefazolin-moxifloxacin combinations. Results.: A total of 292 bacterial isolates were identified. Of these, 255 (87.3%) were Gram-positive and 37 (12.7%) were Gram-negative. Staphylococcus epidermidis (n=227, 77.7%) was the most common organism. Overall susceptibility of isolates was 95.52% to gatifloxacin, 92.83% to moxifloxacin, 90.07% to tobramycin, and 83.56% to cefazolin (p<0.000). Organisms which showed resistance to fourth-generation fluoroquinolones included Staphylococcus epidermidis, Pseudomonas aeruginosa, viridans streptococci, Streptococcus pneumoniae, Staphylococcus aureus, and Escherichia coli. Susceptibilities to gatifloxacin and moxifloxacin were comparable with each other (p=0.312) and with potential susceptibilities to cefazolin-tobramycin (p=0.479), gatifloxacin-cefazolin (p=0.134), and moxifloxacin-cefazolin (p=0.412) combinations. Conclusions.: Monotherapy with moxifloxacin or gatifloxacin can be an effective alternative to cefazolin-tobramycin combination as a first-line empirical therapy for bacterial keratitis. The addition of cefazolin to a fourth-generation fluoroquinolone is of limited value.Keywords
This publication has 20 references indexed in Scilit:
- Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgeryJournal of Cataract & Refractive Surgery, 2006
- Comparison of Topical Gatifloxacin 0.3% and Ciprofloxacin 0.3% for the Treatment of Bacterial KeratitisAmerican Journal of Ophthalmology, 2006
- Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolatesAmerican Journal of Ophthalmology, 2003
- Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibioticsAmerican Journal of Ophthalmology, 2002
- Emerging ciprofloxacin-resistant Pseudomonas aeruginosaAmerican Journal of Ophthalmology, 1999
- The Importance of Initial Management in the Treatment of Severe Infectious Corneal UlcersOphthalmology, 1995
- Efficacy of Ofloxacin vs Cefazolin and Tobramycin in the Therapy for Bacterial KeratitisArchives of Ophthalmology (1950), 1995
- Ultrastructural and Immunohistochemical Features of Coronal AdenomasAmerican Journal of Ophthalmology, 1991
- A Multicenter Study of Pneumocystis ChoroidopathyAmerican Journal of Ophthalmology, 1991
- Antibiotic Susceptibility Testing by a Standardized Single Disk MethodAmerican Journal of Clinical Pathology, 1966